Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions

Biomed Res Int. 2014:2014:481973. doi: 10.1155/2014/481973. Epub 2014 Aug 10.

Authors

Lorenzo Cavagna¹, Lesley-Ann Saketkoo², Andreas Schwarting³, Roberto Caporali¹

Affiliations

¹ Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Viale Golgi 2, 27100 Pavia, Italy.
² Sections of Rheumatology and Pulmonary Medicine, Department of Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA, USA.
³ Division of Rheumatology, Mainz University Hospital and ACURA Rheumatology Center, Kaiser-Wilhelm Street 9-11, Rhineland-Palatinate, 55543 Bad Kreuznach, Germany.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
Antirheumatic Agents / therapeutic use*
Autoimmune Diseases / drug therapy*
Autoimmune Diseases / immunology*
Drug Design
Humans
Molecular Targeted Therapy / methods*
Rheumatic Diseases / drug therapy*
Rheumatic Diseases / immunology*

Substances

Antibodies, Monoclonal
Antirheumatic Agents